Hemodialysis is a medical procedure used to remove waste from the blood of patients with chronic or acute kidney failure. The waste removal helps to maintain electrolyte balance in the patient's body. The procedure works similar to an artificial kidney by filtering the blood through a device called the hemodialyzer. It also prevents accumulation of salts and wastes in blood, which may lead to poisoning. The global hemodialysis market was valued at $71,501 million in 2017 and is expected to reach $99,747 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.
The global hemodialysis market is expected to grow, owing to the increase in geriatric population and incidence of renal diseases, especially end stage renal disease (ESRD). In addition, increase in funding for improved dialysis products and services, rise in incidence of diabetes and hypertension, and shortage of kidneys for transplantation are expected to further propel the market growth. Although the hemodialysis market continues to grow, certain factors hamper the growth of this market. The complications and risks associated with the procedure of hemodialysis, such as severe anemia and fluid overload, drag the market growth. In addition, product recalls in recent years also have a negative impact over the market growth. Conversely, technological advancements leading to better adoption and opportunities in emerging economies are anticipated to offer growth opportunities for the global hemodialysis market.
The hemodialysis market is segmented on the basis of type, product and service, end user, and region. On the basis of type, it is categorized into conventional (3 times per week), daily (6 days a week), and nocturnal (3-6 nights per week). According to product and service, it is categorized into equipment, consumable, drug, and service.
By end user, it is divided into in-center dialysis and home dialysis. Region-wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), Asia-Pacific (Japan, China, Singapore, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis of the overall market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global hemodialysis market.
Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
An in-depth analysis based on region is provided to understand the regional market and facilitate the strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By type
Conventional (3 times per week)
Daily (6 days a week)
Nocturnal (3-6 nights per week)
By product and service
Equipment
Consumable
Drug
Service
By end user
In-center dialysis
Home dialysis
By region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
The list of key players operating in this market includes:
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International, Inc.
Cantel Medical Corp.
DaVita, Inc.
Diaverum
Fresenius Medical Care AG & Co. KGaA
Nikkiso Co., Ltd.
Nipro Corporation
NxStage Medical, Inc.
The other players included in the value chain analysis (and not included in the report) include:
Gambro
Satellite Healthcare, Inc.
MEDIVATORS, Inc.
